“ DetoxiGenomic® Profile”
According to the CDC, precision medicine, also called personalized medicine, is an individualized approach to patient care taking into account genetics, lifestyle, and environmental factors. Single Nucleotide Polymorphisms, or SNPs, are genetic variants that may predispose your patients to numerous chronic diseases. Testing can help clinicians identify a patient’s genetic predispositions and tailor therapeutics accordingly.
Who can benefit from SNP testing?
Researchers have identified thousands of SNPs that relate to almost every chronic disease. Truth is, everybody has SNPs. SNPs are common and generally do not result in life-threatening presentations like genetic mutations, which are rare. SNPs are more subtle and act by reducing cellular functions and ultimately an optimal quality of life. Genomic testing can minimize risk by identifying hidden gene polymorphisms that may promote chronic disease. Many people mistakenly assume that the presence of a SNP means they are destined to experience the associated disease. Fortunately, most genes have flexible expressions and often are influenced by modifiable environmental, diet, and lifestyle factors. In some instances, genotypic SNP testing may prompt phenotypic monitoring of associated biomarkers. For example, if a patient has a polymorphism for MTHFR, homocysteine may be more closely monitored.
SNP testing may be appropriate for patients with:
• Chronic conditions that resist treatment
• Family history of cardiovascular disease, mood disorders, Alzheimer’s, cancer, or autoimmune disease
• Inflammatory conditions
• Cardiovascular disease
• Mood disorders
• Osteoporosis
• Metabolic disorders (insulin resistance)
• Chemical sensitivity
• Asthma and lung problems
• Cognitive decline
